Motivational Interviewing Targeting Pain and Substance Use in Veterans Seeking Service-Connection Payments: A Multisite Randomized Clinical Trial
Authors:
Open Access
- 25 February 2026
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- p. 1-10
Abstract
Background: Veterans filing musculoskeletal disorder (MSD) service claims may also be seeking medical treatment. Objective: To determine the effect of Motivational Interviewing to Activate Pain Support (MAPS) on pain and substance use in veterans who recently filed MSD claims. Participants: A total of 1101 post 9/11 veterans who had filed MSD compensation claims, were not receiving multimodal pain care from VA and had at least moderately severe pain. Interventions: Up to five phone sessions of MAPS compared to treatment-as-usual (TAU). Main Measures: Pain severity subscale of the Brief Pain Inventory (BPI) and number of substances above the low-risk threshold of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). Key Results: Most (87%) veterans offered MAPS participated, and counselors delivered MAPS with good integrity. At week 36, MAPS participants had significantly greater reductions in pain severity than TAU (−0.78 vs. −0.53; mean difference = −0.25, 95% CI −0.44 to −0.06, p = .011), although rates of clinically meaningful improvement were similar between groups (45.4% MAPS vs. 40.8% TAU; OR = 1.21, 95% CI 0.92–1.59, p = .183). The groups did not differ in self-reported number of pain treatment modalities used (TAU = 3.01 modalities vs. MAPS 3.33 modalities, p = .135); however, MAPS participants had, on average, 54% more outpatient encounters for MSDs than those in TAU (MAPS 7.25 vs. TAU 4.58, p < .001). Substance use did not differ between groups. Conclusions: MAPS was associated with more outpatient encounters for MSD and statistically significant reductions in pain severity at week 36; reductions achieving the threshold for clinical significance did not differ by group. Benefits from MAPS, despite pandemic-era disruptions to treatment availability, may have occurred via counselors activating patients to seek MSD treatments, helping them navigate pain care systems, and offering patients support. Design: Two-arm, parallel group 36-week multisite randomized pragmatic clinical trial (Clinical Trials.gov: NCT 04062214). Trial Registration: ClinicalTrials.gov registration (NCT04062214) on August 19, 2019.Keywords
Funding Information
- National Center for Complementary and Integrative Health (UG3/UH3-AT0009757)
This publication has 27 references indexed in Scilit:
- An Analysis of the Role of Mental Health in a Randomized Trial of a Walking Intervention for Black Veterans With Chronic PainThe Journal of Pain, 2022
- Assessing the impact of the COVID-19 pandemic on pragmatic clinical trial participantsContemporary Clinical Trials, 2021
- Beyond face-to-face individual counseling: A systematic review on alternative modes of motivational interviewing in substance abuse treatment and preventionAddictive Behaviors, 2017
- The Efficacy of Motivational Interviewing in Adults With Chronic Pain: A Meta-Analysis and Systematic ReviewThe Journal of Pain, 2016
- Association Between Substance Use Disorder Status and Pain-Related Function Following 12 Months of Treatment in Primary Care Patients With Musculoskeletal PainThe Journal of Pain, 2011
- Development and Initial Validation of the PEG, a Three-item Scale Assessing Pain Intensity and InterferenceJournal of General Internal Medicine, 2009
- Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT RecommendationsThe Journal of Pain, 2008
- Computer-Based Brief InterventionAmerican Journal of Preventive Medicine, 2007
- Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scaleEuropean journal of pain, 2004
- Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatmentDrug and Alcohol Dependence, 2004